Published on: Dec 13, 2017 at https://finance.yahoo.com/news/daiichi-sankyo-initiates-pivotal-phase-130000408.html?soc_src=mail&soc_trk=ma

Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Advanced Gastric Cancer

By : https://finance.yahoo.com/news/daiichi-sankyo-initiates-pivotal-phase-130000408.html?soc_src=mail&soc_trk=ma

A new phase 2 study in Japan and South Korea will evaluate the efficacy and safety of DS-8201 in ER2-expressing gastric cancer.

Read More
SHARE